CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Evidence-Based Quality Improvement Plus Facilitationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01875861
NCT01875861N/ACompleted
CompareCT.gov

Monitoring and Management for Metabolic Effects of Antipsychotics

VA Office of Research and Development·interventional·Posted Jun 12, 2013·Updated Feb 12, 2019

In Brief

A clinical study evaluating Evidence-Based Quality Improvement Plus Facilitation for Mental Health and Psychotic Disorders. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The purpose of this study is to test an approach for implementing guideline recommendations for assessing and managing metabolic side effects (including weight gain, diabetes, elevated lipids) in patients prescribed antipsychotic medications.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMental Health, Psychotic Disorders
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJun 12, 2013
Enrollment StartJan 1, 2011
Primary CompletionMar 1, 2016
Study CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 13.1 years ago

Interventions

Evidence-Based Quality Improvement Plus Facilitationother

The intervention involves researchers partnering with clinical stakeholders, offering tailoring in local implementation strategies to address barriers to metabolic side-effect monitoring and management. External facilitation to support, problem-solve and refine implementation will be provided for a six-month implementation phase.